Manufacturing Chemist
  • Home
  • Categories
    • Ingredients
    • Analysis
    • Manufacturing
    • Finance
    • Company News
    • Regulatory
    • Drug Delivery
    • Research & Development
    • Sustainability
  • Pharma 5.0
  • Events
  • Directory
  • Editorial team
  • Search
    • Close search
  • Subscribe
  • Login
    • Password
      Password
      Forgot password? Close login form
  • Home
  • Company News

Company News

Affimed Therapeutics hires chief commercial officer Affimed Therapeutics hires chief commercial officer Affimed Therapeutics hires chief commercial officer Adi Hoess joins the Heidelberg-based firm Takeda makes European appointments Takeda makes European appointments Hires ceo of Takeda Pharmaceuticals Europe and md of Takeda Global R&D Centre Europe Quay Pharma appoints scientific manager Quay Pharma appoints scientific manager Quay Pharma appoints scientific manager Mark Powell takes on wider technical responsibility Russell Group restructures Russell Group restructures Russell Group restructures With Ray Singh becoming md, Martin Chipperfield moves up to sales and marketing director PharmaDiagnostics appoints director of assay development PharmaDiagnostics appoints director of assay development PharmaDiagnostics appoints director of assay development Former pharma department head joins Belgian firm Synexus appoints regional director in Ukraine Synexus appoints regional director in Ukraine Dmytro Razborov takes responsibility for operations and business development Lehuu joins marine biotech Aquapharm Lehuu joins marine biotech Aquapharm Lehuu joins marine biotech Aquapharm Takes responsibility for business development in biopharmaceuticals at the Scotland-based firm ClinTec makes a promotion ClinTec makes a promotion Stuart Grant takes newly created role of associate director of regulatory affairs TxCell names François Meyer as chief executive TxCell names François Meyer as chief executive Prepares to take lead product candidates into clinical trials Eli Lilly announces vp of oncology research Eli Lilly announces vp of oncology research Greg Plowman will oversee cancer research for Lilly and ImClone BioAlliance Pharma makes appointment BioAlliance Pharma makes appointment Judith Greciet put in charge of operations and r&d as deputy chief operating officer SCM staff slide for charity SCM staff slide for charity SCM staff slide for charity From the top of the Baltic in Gateshead, UK across the River Tyne Send in your entries to IChemE awards Send in your entries to IChemE awards Presentations at ICC, Birmingham on 3 November ECEHH appoints new director ECEHH appoints new director Professor Lora Fleming is a leading expert in the environment and public health UBM Live appoints new md of pharma portfolio UBM Live appoints new md of pharma portfolio UBM Live appoints new md of pharma portfolio Rudge will direct the continued growth and development of the CPhI, ICSE, P-MEC and BioPh brands Get them while they’re young Get them while they’re young Get them while they’re young School children get to grips with particle analysis with Whitehouse Scientific
  • Previous
  • 1
  • …
  • 178
  • 179
  • 180
  • 181 (current)
  • 182
  • 183
  • 184
  • …
  • 215
  • Next

Trending Articles

  1. FUJIFILM Biotechnologies transitions leadership to drive next phase of operational excellence FUJIFILM Biotechnologies today announced a planned leadership evolution as the Company enters its next phase of execution and sustainable growth
  2. Clinilabs announces medical leadership appointments Bob Dagher, M.D., named chief medical officer and Waqar Ahmed Siddiqui, M.D., named principal investigator
  3. Anders Fogelberg appointed president and CEO of BICO Group AB BICO appoints current Chief Commercial Officer Anders Fogelberg as President and CEO, effective September 1, 2026
  4. Clinilabs announces leadership expansion Laura Shannon joins the organisation as Chief Executive Officer while Gary Zammit, the Company’s founder, assumes the role of Executive Chairperson
  5. As new CTO, Christian Reichardt is driving the technological advancement of Optima Pharma This investment is driven by growth areas such as biologics, GLP-1 products, and other sterile pharmaceuticals, as well as the increasing demand for isolator and high-potency technologies

Upcoming event

CPhI Milan

6–8 October 2026 | Exhibition | Fiera Milano, Italy
See all

Become a Subscriber

Subscribe now Already a subscriber? Sign in here. Find out more

Get our newsletter

Follow us

  • LinkedIn
  • About Manufacturing Chemist
  • About HPCi Media
  • Newsletter sign up
  • Contact Us
  • Advertise
  • Terms and Conditions
  • Privacy
© HPCi Media Limited | Registered in England No. 06716035 | VAT GB 939828072 | a Claverley Group company Registered office address:
One Anchorage Avenue,
Shrewsbury Business Park,
Shrewsbury,
SY2 6FG, UK.